Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
After finishing at $3.85 in the prior trading day, Monte Rosa Therapeutics Inc (NASDAQ: GLUE) closed at $4.22, up 9.61%. In other words, the price has increased by $9.61 from its previous closing price. On the day, 0.67 million shares were traded.
Ratios:
Our goal is to gain a better understanding of GLUE by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 0.70 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 6.83. For the most recent quarter (mrq), Quick Ratio is recorded 2.40 and its Current Ratio is at 2.40. In the meantime, Its Debt-to-Equity ratio is 0.19 whereas as Long-Term Debt/Eq ratio is at 0.17.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on December 19, 2024, Downgraded its rating to Equal Weight and sets its target price to $11 from $14 previously.
On February 15, 2024, Wedbush started tracking the stock assigning a Outperform rating and target price of $11.
Wells Fargo Upgraded its Equal Weight to Overweight on January 03, 2023, while the target price for the stock was maintained at $18.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 24 ’25 when Leo Chandra P. bought 10,000 shares for $5.84 per share. The transaction valued at 58,383 led to the insider holds 10,000 shares of the business.
Versant Venture Capital VI, L. sold 89,990 shares of GLUE for $869,240 on Oct 28 ’24. The 10% Owner now owns 2,007,948 shares after completing the transaction at $9.66 per share. On Oct 29 ’24, another insider, Versant Venture Capital VI, L., who serves as the 10% Owner of the company, sold 67,905 shares for $9.16 each. As a result, the insider received 621,801 and left with 1,573,453 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 3.43 while its Price-to-Book (P/B) ratio in mrq is 1.16.
Stock Price History:
Over the past 52 weeks, GLUE has reached a high of $12.40, while it has fallen to a 52-week low of $3.21. The 50-Day Moving Average of the stock is -18.35%, while the 200-Day Moving Average is calculated to be -31.40%.
Shares Statistics:
A total of 61.51M shares are outstanding, with a floating share count of 45.99M. Insiders hold about 25.23% of the company’s shares, while institutions hold 83.29% stake in the company.
